The closing price of Altimmune Inc (NASDAQ: ALT) was $10.39 for the day, up 3.59% from the previous closing price of $10.03. In other words, the price has increased by $+0.36 from its previous closing price. On the day, 3017559 shares were traded. ALT stock price reached its highest trading level at $10.52 during the session, while it also had its lowest trading level at $10.02.
Ratios:
Our analysis of ALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.89 and its Current Ratio is at 12.89. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on January 24, 2024, initiated with a Neutral rating and assigned the stock a target price of $13.
On March 22, 2023, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $20 to $6.
On December 01, 2022, Goldman started tracking the stock assigning a Buy rating and target price of $20.Goldman initiated its Buy rating on December 01, 2022, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’23 when Drutz David bought 300 shares for $2.88 per share. The transaction valued at 862 led to the insider holds 29,785 shares of the business.
Eisenstadt Richard I bought 10,000 shares of ALT for $43,140 on Mar 24 ’23. The Chief Financial Officer now owns 22,010 shares after completing the transaction at $4.31 per share. On Mar 23 ’23, another insider, Harris Matthew Scott, who serves as the Chief Medical Officer of the company, bought 10,000 shares for $4.22 each. As a result, the insider paid 42,200 and bolstered with 33,311 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 557.71M and an Enterprise Value of 417.71M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1993.77 while its Price-to-Book (P/B) ratio in mrq is 3.65. Its current Enterprise Value per Revenue stands at 1.50k whereas that against EBITDA is -5.31.
Stock Price History:
Over the past 52 weeks, ALT has reached a high of $14.84, while it has fallen to a 52-week low of $2.09. The 50-Day Moving Average of the stock is 10.43, while the 200-Day Moving Average is calculated to be 5.20.
Shares Statistics:
ALT traded an average of 8.56M shares per day over the past three months and 8.19M shares per day over the past ten days. A total of 53.73M shares are outstanding, with a floating share count of 53.18M. Insiders hold about 1.02% of the company’s shares, while institutions hold 67.64% stake in the company. Shares short for ALT as of Feb 15, 2024 were 11.55M with a Short Ratio of 1.35, compared to 10.66M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 21.50% and a Short% of Float of 21.68%.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of -$0.43 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.58, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.29 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.26 and -$1.57 for the fiscal current year, implying an average EPS of -$1.47. EPS for the following year is -$1.68, with 8 analysts recommending between -$0.86 and -$2.44.
